Relay Therapeutics to report third quarter 2024 results on November 6
benzinga.com — October 30, 2024, 09:01 PM UTC
Relay Therapeutics will release its financial results for the third quarter of 2024 on November 6, after U.S. markets close. This announcement marks a regular update for the clinical-stage precision medicine company.
The company focuses on improving drug discovery using advanced computational and experimental technologies. Its Dynamo® platform targets challenging protein issues in oncology and genetic diseases.
This upcoming report will provide insights into Relay Therapeutics' financial performance and corporate developments since its last update.
Article metrics
Significance4.0
Scale & Impact4.4
Positivity6.2
Credibility7.5